Skip to Main Content

Paper Details

CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients.
Am J Transplant
6
2022
Author NameAffiliation
Joshua BlatterWashington University in St. Louis
Gregory A StorchWashington University in St. Louis
  • 1 - 2

Datasets

Release 1.2